A detailed history of Fieldpoint Private Securities, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 4,428 shares of BMY stock, worth $260,277. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,428
Previous 6,441 31.25%
Holding current value
$260,277
Previous $470,000 27.45%
% of portfolio
0.1%
Previous 0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $146,184 - $160,999
-2,013 Reduced 31.25%
4,428 $341,000
Q1 2022

Apr 07, 2022

BUY
$61.48 - $73.72 $11,558 - $13,859
188 Added 3.01%
6,441 $470,000
Q4 2021

Jan 24, 2022

SELL
$53.63 - $62.52 $70,523 - $82,213
-1,315 Reduced 17.38%
6,253 $390,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $7,751 - $9,079
-131 Reduced 1.7%
7,568 $448,000
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $95,589 - $104,096
1,544 Added 25.09%
7,699 $519,000
Q1 2021

Apr 23, 2021

SELL
$59.34 - $66.74 $81,651 - $91,834
-1,376 Reduced 18.27%
6,155 $389,000
Q4 2020

Jan 28, 2021

BUY
$57.74 - $65.43 $142,906 - $161,939
2,475 Added 48.95%
7,531 $467,000
Q3 2020

Oct 23, 2020

BUY
$57.43 - $63.64 $31,988 - $35,447
557 Added 12.38%
5,056 $305,000
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $37,716 - $44,093
688 Added 18.05%
4,499 $265,000
Q1 2020

May 11, 2020

SELL
$46.4 - $67.43 $5,289 - $7,687
-114 Reduced 2.9%
3,811 $212,000
Q4 2019

Feb 10, 2020

SELL
$49.21 - $64.19 $4,773 - $6,226
-97 Reduced 2.41%
3,925 $252,000
Q3 2019

Nov 07, 2019

SELL
$42.77 - $50.71 $7,142 - $8,468
-167 Reduced 3.99%
4,022 $204,000
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $435,982 - $482,101
-9,771 Reduced 69.99%
4,189 $190,000
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $15,295 - $18,238
339 Added 2.49%
13,960 $666,000
Q4 2018

Feb 11, 2019

SELL
$48.76 - $63.23 $43,835 - $56,843
-899 Reduced 6.19%
13,621 $708,000
Q3 2018

Nov 15, 2018

BUY
$55.19 - $62.25 $49,726 - $56,087
901 Added 6.62%
14,520 $901,000
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $71,550 - $89,179
-1,416 Reduced 9.42%
13,619 $754,000
Q1 2018

May 08, 2018

BUY
$59.92 - $68.98 $25,825 - $29,730
431 Added 2.95%
15,035 $951,000
Q4 2017

Feb 15, 2018

SELL
$59.94 - $65.35 $29,850 - $32,544
-498 Reduced 3.3%
14,604 $895,000
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $834,083 - $962,601
15,102
15,102 $963,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.